SNN vs EW โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EW Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edwards Lifesciences Corp (EW) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SNN counters with relative strength in Valuation. Fundamentally, SNN trades at 13.2x Forward P/E with 14.2% operating margin (+4.6% YoY revenue) versus EW at 31.6x Forward P/E and 28.8% operating margin (+10.5% YoY). In options structure, SNN sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SNN | EW | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $13.2B | $60.8B | Larger Scale | EW |
| Trailing P/E Ratio Valuation | 21.4x | 61.5x | Lower Multiple | SNN |
| Forward P/E Ratio Valuation | 13.2x | 31.6x | Lower Multiple | SNN |
| Revenue Growth (YoY) Growth | +4.6% | +10.5% | Higher Growth | EW |
| Operating Margin (TTM) Profitability | 14.2% | 28.8% | Higher Margin | EW |
| Net Profit Margin Profitability | 10.1% | 15.3% | Higher Margin | EW |
| Return on Equity (ROE) Capital Efficiency | 11.8% | 9.3% | Higher ROE | SNN |
| 52-Week Range Position Momentum | 45% ($26โ$37) | 96% ($75โ$108) | Stronger Trend | EW |
| Beta / 30D Volatility Risk Regime | 0.28ฮฒ ยท 38% Vol | 0.44ฮฒ ยท 24% Vol | Lower Realized Risk | EW |
| Unified Institutional Score Composite Signal | 42.0 / 100 (HOLD) | 31.5 / 100 (SELL) | Higher Composite | SNN |